Elekta, Inc. recalls MOSAIQ Oncology Information System
- Recall date
- July 15, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2293-2016
- FDA classification
- Class II
- Brand / firm
- Elekta, Inc.
- Sold / distributed
- Worldwide distribution. US nationwide, Antigua and Barbuda, Australia, Austria, Bahamas, Bahrain, Canada, Czech Republic, Germany, Hungary, South Africa, Spain, Sweden, Turkey, and United Kingdom
Why it was recalled
It is possible that a change to an Order Set will not be saved in the current open Care Plan. This can result in a wrong chemo dose in the order.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
MOSAIQ Oncology Information System
Get recall alerts
Free email alert whenever Elekta, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Elekta, Inc.